有权 发表于 2025-3-23 10:16:39

http://reply.papertrans.cn/1/43/4300/4300-11.png

ascetic 发表于 2025-3-23 14:35:27

Submitted on: 25 January 2007.
Revised on: 18 February 2007.
Accepted on: 13 April 2007.

___________________BULLETIN DU CANCER---ELSEVIER MASSON, CORPORATION OFFICE

碎石头 发表于 2025-3-23 21:50:52

http://reply.papertrans.cn/1/43/4300/4300-13.png

商议 发表于 2025-3-23 23:48:53

Submitted on: 05 August 2011.
Revised on: 31 October 2011.
Accepted on: 11 December 2011.

___________________BULLETIN DU CANCER---ELSEVIER MASSON, CORPORATION OFFICE

Estimable 发表于 2025-3-24 04:19:22

http://reply.papertrans.cn/1/43/4300/4300-15.png

Barter 发表于 2025-3-24 06:58:58

http://reply.papertrans.cn/1/43/4300/4300-16.png

一致性 发表于 2025-3-24 13:43:03

Submitted on: 31 March 2008.
Revised on: 26 June 2008.
Accepted on: 15 July 2008.

___________________BULLETIN DU CANCER---ELSEVIER MASSON, CORPORATION OFFICE

Ascendancy 发表于 2025-3-24 18:17:39

http://reply.papertrans.cn/1/43/4300/4300-18.png

攀登 发表于 2025-3-24 20:33:00

http://reply.papertrans.cn/1/43/4300/4300-19.png

CONE 发表于 2025-3-24 23:19:11

Submitted on: 16 August 2001.
Revised on: 11 November 2001.
Accepted on: 27 November 2001.

___________________BULLETIN DU CANCER---ELSEVIER MASSON, CORPORATION OFFICE
页: 1 [2] 3 4
查看完整版本: SCIE期刊BULLETIN DU CANCER 2024/2025影响因子:1.117 (B CANCER) (0007-4551). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded